2 completed, 2 unknown, 1 recruiting. 2 Phase 2, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
Follow Natulan: new trials by email Literature Review of Natulan trials Research Report on Natulan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Biospecimen Collection, Bleomycin Sulfate, Brentuximab Vedotin - Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 1875 | 2023-05-11 | 2026-10-28 |
| Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma | Phase 2 | Completed | AIDS Malignancy Consortium | 7 | 2016-09-15 | 2022-10-10 |
| Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol Natulan, ABVD - Advanced Hodgkin's Lymphoma | Not applicable | Unknown | Lee's Pharmaceutical Limited | 92 | 2016-06-01 | 2018-09-04 |
| Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) ESCALATED BEACOPP, CONVENTIONAL ABVD - HODGKIN LYMPHOMA | Phase 2 | Unknown | Ospedale Santa Croce-Carle Cuneo | 450 | 2008-06-01 | 2015-10-19 |
| Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma Bleomycin, Etoposide, Doxorubicin - Hodgkin Lymphoma | Phase 3 | Completed | Fondazione Michelangelo | 331 | 2000-03-01 | 2015-08-13 |
Hodgkin Disease (2) · Lymphoma, AIDS-Related (1)
AIDS Malignancy Consortium (1) · Fondazione Michelangelo (1) · Lee's Pharmaceutical Limited (1) · National Cancer Institute (NCI) (1) · Ospedale Santa Croce-Carle Cuneo (1)
Italy (2) · Canada (1) · Israel (1) · Kenya (1) · Puerto Rico (1) · United States (1) · Zimbabwe (1)
Alessandro M Gianni, MD (1) · Kara M Kelly (1) · Robert Strother (1)
PMID 21774708, PMID 29360414, PMID 32946355, PMID 37505794, PMID 40135712
U01CA121947 (1), U10CA180886 (1)